ARMONK, NY: Novo Nordisk, a provider of healthcare solutions, and IBM Watson Health partner to offer diabetes solutions on Watson Health Cloud. The partnership enables Novo Nordisk to reap benefits from its cognizance in diabetes by leveraging IBM Watson.

The partnership will be tapping insights from real-time, real-world evidence of Novo Nordisk diabetes treatments and devices to enhance diabetes care. Novo Nordisk will be leveraging Watson Health Cloud to boost its offering for the people with diabetes and their healthcare professionals.

 “Working with ambitious partners like IBM Watson Health helps us explore the opportunities presented by an increasingly digitalized healthcare system. We aim to leverage our combined capabilities to improve the lives of people with diabetes by making the management of the condition more simple, effective and measurable,” says Jakob Riis, executive vice president, Novo Nordisk.

The cognitive computing platform, IBM Watson delivered through the cloud represents a new era of computing processing huge amount of large data’s to uncover patterns understanding of complex questions in natural language, proposing evidence-based answers, and learns from each interaction. The Watson Health Cloud pools diverse data of clinical, research and social data from various health sources providing a secure cloud-based data sharing with advanced analytics and cognitive technologies.

The Watson Health Cloud allows developing health and wellness solutions through its platform by allowing a massive amount of personal health data being created and shared every day.

“IBM is excited to work with Novo Nordisk, a global leader in diabetes, to help the company create new e-health solutions on the Watson Health Cloud-accessing cognitive computing to help personalize care”, says Deborah DiSanzo, general manager of IBM Watson Health.